Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis
Status: | Completed |
---|---|
Conditions: | Arthritis, Rheumatoid Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - 75 |
Updated: | 8/18/2018 |
Start Date: | September 14, 2016 |
End Date: | June 25, 2018 |
A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Efficacy and Safety of JTE-051 Administered for 12 Weeks to Subjects With Active Rheumatoid Arthritis (MOVE-RA)
This study will evaluate the efficacy, safety, tolerability and pharmacokinetics (PK) of
JTE-051 administered for 12 weeks in subjects with active rheumatoid arthritis who are
receiving background non-biologic disease-modifying anti-rheumatic drug therapy.
JTE-051 administered for 12 weeks in subjects with active rheumatoid arthritis who are
receiving background non-biologic disease-modifying anti-rheumatic drug therapy.
Inclusion Criteria:
- A diagnosis of RA prior to the Screening Visit.
- Active disease despite ongoing therapy with up to two non-biologic disease-modifying
anti-rheumatic drugs, including methotrexate at both the Screening and Baseline
Visits.
- Screening hs-CRP ≥1.2 x upper limit of normal (ULN).
Exclusion Criteria:
- Prior/current exposure to biologic and/or kinase inhibitor therapy.
- Known history or presence of polyneuropathy of any cause and no presence of clinically
active compression neuropathy, radiculopathy or plexopathy at the Screening Visit.
- Positive test results for human immunodeficiency (HIV) virus, hepatitis B virus or
hepatitis C (HCV) virus at the Screening Visit.
- Positive drug of abuse and alcohol test results.
- History of a clinically-significant infection that required oral antimicrobial or
antiviral therapy within 8 weeks prior to Day 1.
We found this trial at
5
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials